A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo

Cholangiocarcinoma (CCA) is a biliary tree malignancy with a dismal prognosis. Tumor microenvironment (TME), including cancer-associated fibroblasts (CAFs) has been shown to be involved in drug resistance. To model the interactions between cancer cells and the TME, we established CCA complex patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ling, Zhou, Yang, Zhang, Yicheng, Hu, Haijie, Mao, Hai-Quan, Selaru, Florin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950944/
https://www.ncbi.nlm.nih.gov/pubmed/36843847
http://dx.doi.org/10.1016/j.isci.2023.106095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950944/
https://www.ncbi.nlm.nih.gov/pubmed/36843847
http://dx.doi.org/10.1016/j.isci.2023.106095

Ejemplares similares